Dan Weng
Impact in
- Immunology top 2%
- Immune Response and Inflammation
- interferon and immune responses
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
Papers in ⓘ
-
- Sirtuins and Resveratrol in Medicine 3
-
- Effects and risks of endocrine disrupting chemicals 7
- Co-authors
- Egil Lien (7 shared papers)Megan K. Proulx (4 shared papers)Katherine A. Fitzgerald (4 shared papers)John Bertin (4 shared papers)Jon D. Goguen (4 shared papers)Gregory I. Vladimer (5 shared papers)Peter J. Gough (2 shared papers)Michelle A. Kelliher (2 shared papers)
- Journals
- Immunity (2 papers)Environmental Toxicology (2 papers)Journal of Biological Chemistry (2 papers)International Immunopharmacology (2 papers)Toxicology and Applied Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Dan Weng
45 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Immunology 1.0k
- Nephrology 183
- Molecular Biology 1.7k
- Applied Microbiology and Biotechnology 35
- Hematology 171
Countries citing papers authored by Dan Weng
This map shows the geographic impact of Dan Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Weng more than expected).
Fields of papers citing papers by Dan Weng
This network shows the impact of papers produced by Dan Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Weng. The network helps show where Dan Weng may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Weng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pathogen blockade of TAK1 triggers caspase-8–dependent cleavage of gasdermin D and cell death Hit paper breakdown → | 2018 | 800 |
| 2 | 1994 | 436 | |
| 3 | 2012 | 293 | |
| 4 | 2014 | 243 | |
| 5 | 2006 | 166 | |
| 6 | 2015 | 148 | |
| 7 | 2016 | 139 | |
| 8 | 2013 | 133 | |
| 9 | 2016 | 93 | |
| 10 | 2020 | 74 | |
| 11 | 2015 | 73 | |
| 12 | 2019 | 61 | |
| 13 | 2008 | 61 | |
| 14 | 2018 | 42 | |
| 15 | 2020 | 39 | |
| 16 | 2022 | 39 | |
| 17 | 2018 | 24 | |
| 18 | 2024 | 23 | |
| 19 | 2020 | 19 | |
| 20 | 2022 | 16 |
About Dan Weng
Dan Weng is a scholar working on Geriatrics and Gerontology, Health, Toxicology and Mutagenesis, Hepatology, Applied Microbiology and Biotechnology and Cell Biology, having authored 47 papers that have together received 3.1k indexed citations. Recurring topics across this work include Endoplasmic Reticulum Stress and Disease (7 papers), Effects and risks of endocrine disrupting chemicals (7 papers), Inflammasome and immune disorders (6 papers), Liver Disease Diagnosis and Treatment (4 papers), Yersinia bacterium, plague, ectoparasites research (3 papers), Sirtuins and Resveratrol in Medicine (3 papers), Immune Response and Inflammation (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). The work is most often cited by research in Immunology (1.0k citations), Nephrology (183 citations), Molecular Biology (1.7k citations), Applied Microbiology and Biotechnology (35 citations) and Hematology (171 citations). Dan Weng has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Egil Lien, Megan K. Proulx, Katherine A. Fitzgerald, John Bertin, Jon D. Goguen, Gregory I. Vladimer, Peter J. Gough, Michelle A. Kelliher, Robyn Marty-Roix and Valentı́n Fuster. Their work appears in journals such as Immunity, Environmental Toxicology, Journal of Biological Chemistry, International Immunopharmacology and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.